AstraZeneca logo

AstraZeneca

AZNCF | OTC
Chart Builder DCF Calculator
$189.90
-$2.60 (-1.35%)
At close: Mar 13, 2026, 9:30 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
12.4B 8.69B 6.9B 2.5B -265M 3.92B
Depreciation & Amortization
5.73B 5.07B 4.93B 5.48B 6.53B 3.15B
Stock-Based Compensation
n/a n/a 579M 619M 615M 277M
Other Working Capital
-1.14B 862M 969M -184M 444M 982M
Other Non-Cash Items
-2.42B -1B -2.37B -1.93B -2.32B -2.63B
Deferred Income Tax
n/a n/a n/a -619M -615M -277M
Change in Working Capital
-1.14B -893M 300M 3.76B 2.02B 361M
Operating Cash Flow
14.58B 11.86B 10.35B 9.81B 5.96B 4.8B
Capital Expenditures
-5.91B -4.59B -3.78B -2.57B -2.2B -2.61B
Cash Acquisitions
-1.24B -3.93B -1.18B -1.06B -9.43B -830M
Purchase of Investments
-229M -96M -136M -159M -184M -119M
Sales Maturities Of Investments
131M 108M 129M 42M 105M 2.13B
Other Investing Acitivies
-2.66B -2.14B -1.52B 789M 654M 1.14B
Investing Cash Flow
-6.81B -7.98B -4.06B -2.96B -11.06B -285M
Debt Repayment
-1.65B 1.81B -965M -1.2B 7.89B 1.65B
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
-4.97B -4.63B -4.48B -4.36B -3.86B -3.57B
Other Financial Acitivies
-442M -1.13B -1.15B -1.29B -418M -308M
Financial Cash Flow
-7.54B -4B -6.57B -6.82B 3.65B -2.2B
Net Cash Flow
269M -208M -346M -55M -1.51B 2.32B
Free Cash Flow
8.67B 7.28B 6.57B 7.24B 3.76B 2.19B
Adj. Free Cash Flow
8.67B 7.28B 5.99B 6.62B 3.15B 1.92B
Maintenance CapEx
-4.45B -2.94B -3.14B -486.39M n/a -1.16B
Growth CapEx
-1.45B -1.65B -640.12M -2.08B -2.2B -1.45B
Owner Earnings
10.12B 8.92B 7.21B 9.32B 5.96B 3.64B

© 2026 bestshares.com. All rights reserved.